Analysis Topic: Companies Analysis
The analysis published under this topic are as follows.
Sunday, April 21, 2013
Keeping The Electric Cars On The Road / Companies / Electric Cars
By: Andrew_McKillop
THE ROAD TO NOWHERE
Even if a large number of electric car producers - like Tesla Motor and Fisker Automotive - have major problems producing their cars, in the Fisker case having developed the ultimate dangerous car, the Karma which can burn under water and is banned from sale at present, the urgent pitch for all-electric cars continues. Favoured themes are that "we" must wean western society off oil and save the world's climate with "zero emission" cars (needing no fossil energy to produce, running on roads built with recycled bottle tops and organic household waste!), but the basic reason is a lot simpler.
Friday, April 19, 2013
Intel Paints a Bleak Picture for Desktop PC's / Companies / Tech Stocks
By: Profit_Confidential
Personal computer (PC) sales are on the decline.
It’s clearly not a surprise whatsoever, as we have seen this trend developing for years following the major push of tablets into the marketplace, according to my stock analysis.
We have seen all of the PC makers report declining sales and the need to re-invent and adapt to the rapidly changing environment for mobile devices.
Friday, April 19, 2013
How to Find the Best Dividend Paying Stocks / Companies / Dividends
By: Money_Morning
Diane Alter writes: It's only April, but it appears dividend payouts this year will soar past 2012's tally - meaning all investors need to know how to find the best dividend stocks or risk missing out on record-high yield.
Barron's reports that in Q1, 944 of approximately 10,000 U.S. companies boosted payouts, either by increases, extras or resumption. That was up a hefty 39.4% from 677 companies a year ago.
Read full article... Read full article...
Wednesday, April 17, 2013
Are Corporate Earnings Expectations Realistic? / Companies / Corporate Earnings
By: John_Mauldin
In today’s Outside the Box, Sheraz Mian, Director of Research for Zacks Investment Research, gives us a thorough overview of corporate earnings trends for the past several quarters, along with consensus expectations for this year and next. Then he asks, “How realistic are these expectations?”
Not very, he says, and proceeds to tell us why. If we accept his analysis – and he admits right up front that it runs counter to the consensus – then we should be asking ourselves, how does a potential falloff in earnings vs. expectations matter, and why is it important at this particular juncture? I’ll let Sheraz answer those questions, too – he does so convincingly – but I’ll just add that his analysis is a significant piece in the puzzle we’re all putting together here in this tipping-point year of 2013.
Read full article... Read full article...
Wednesday, April 17, 2013
Why Facebook is Finished / Companies / Tech Stocks
By: Money_Morning
David Zeiler writes: Facebook Inc. (Nasdaq: FB) is starting to get a taste of what it means to be the king of the social media hill.
Small and more nimble competitors with novel ideas have sprung up and begun to entice young users away from the No. 1 social media platform - a bad omen for Facebook stock, which 11 months after its IPO still trades 29% below its offer price.
Read full article... Read full article...
Wednesday, April 17, 2013
Investing in Biotech Stem Cell Research Companies / Companies / BioTech
By: TLSReport
Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective. The Alliance for Regenerative Medicine chairman and Organogenesis Inc. president and CEO asserts that though the regenerative medicine and cell technology industry is still largely in phase 1/2, phase 3 and commercial success are imminent. In this interview with The Life Sciences Report, MacKay explains the promise of cell therapies for both patient health and investors' portfolios.
The Life Sciences Report: Congratulations on being elected chairman of the board of the Massachusetts Biotechnology Council (MassBio). After almost three decades, it's the nation's oldest biotech trade organization. That really speaks to the respect that your peers have for you. Could you tell me a bit about MassBio? What is it about?
Read full article... Read full article...
Tuesday, April 16, 2013
The Trend In U.S. Housing Is Up... And Taking Paint With It / Companies / Housing Stocks
By: DailyWealth
Everywhere we look, we see more confirmation that Steve was "right on" with his bullish housing call from two years ago...
Over the past year, we've pointed to uptrends in Home Depot, homebuilder stocks, and "fixture" suppliers as evidence the housing market is improving. These home-specific stocks are among the biggest stock-market winners of the past few years.
Tuesday, April 16, 2013
Why It's Time to Sell Too Big to Fail Banks / Companies / Banking Stocks
By: Money_Morning
Shah Gilani writes: I'm not buying any bank stocks here. I don't own any at present. And if I did, I'd either sell them or at least hedge them.
It's not that they're doing poorly. They're not. Bank stocks have been strong because they've been making record profits. It's been a good ride if you're a Too Big To Fail bank or a shareholder.
Read full article... Read full article...
Monday, April 15, 2013
Growing Cash Mountains, Will Corporations Stop Hoarding and Pay Out? / Companies / Investing 2013
By: Profit_Confidential
Mitchell Clark writes:Corporations, like investors everywhere, are very reticent about current business conditions. They have been this way for years. And they have way too much cash, which is why dividends have been increasing.
The financial crisis really was the catalyst for a huge change in the way corporations allocate their capital. Corporations hunkered down on costs and became extremely tight with their money.
Monday, April 15, 2013
U.S. Homebuilder Stocks Will Soar / Companies / Housing Stocks
By: Investment_U
Alexander Green writes: During the housing bubble a few years ago, I editorialized repeatedly [Alex nailed it in 2006] that the whole affair was likely to end badly for speculators, mortgage companies and – not least of all – homebuilders.
It wasn’t just a lucky call.
Read full article... Read full article...
Monday, April 15, 2013
How to Profit from North Korea with Nuclear Missiles / Companies / Investing 2013
By: Money_Morning
William Patalon writes: For months now, North Korea has been threatening to launch a nuclear missile strike against the U.S. mainland.
However, the Pentagon has been quite confident in its assertions that the reclusive country doesn't have the technology to actually put a nuclear warhead atop a ballistic missile.
Read full article... Read full article...
Saturday, April 13, 2013
The Seeds Of Suicide: How Monsanto Destroys Farming / Companies / Agricultural Commodities
By: Global_Research
Vandana Shiva writes: Monsanto’s talk of ‘technology’ tries to hide its real objectives of control over seed where genetic engineering is a means to control seed,
“Monsanto is an agricultural company.
We apply innovation and technology to help farmers around the world \produce more while conserving more.”
Read full article... Read full article...
Friday, April 12, 2013
Stocks that Can Mend the Biotech Market / Companies / BioTech
By: TLSReport
Markets are not efficient—at least not in the short term. WBB Securities President Stephen Brozak admits to frustration when he sees small-cap companies with valuations that are disengaged from market realities. But Brozak's experience as a biotech investor, banker and analyst has taught him to be patient with these disconnection syndromes, and he now delights in prospects offered by select bargain-basement opportunities. In this interview with The Life Sciences Report, Brozak touches on 10 names that have been flying far below the radars of most investors.
The Life Sciences Report: Steve, you have something you'd like to get off your mind. Tell me.
Friday, April 12, 2013
U.S. Taxpayers Could Profit from Fannie Mae Bailout / Companies / Credit Crisis Bailouts
By: Bloomberg
In his first TV interview since the company reported record profits, Fannie Mae CEO Tim Mayopoulos told Bloomberg TV's Peter Cook today that U.S. taxpayers could see a net gain from their bailout as the housing market rebounds. Mayopoulos said, "I do think, given the strength of our future profitability, that it is possible that we will be able to pay dividends that would be equal to or greater than the amount of money that we've received from the Treasury Department."
Thursday, April 11, 2013
The Truth About The Impact Of Stocks Dividend Reinvesting / Companies / Dividends
By: Charles_Carnevale
There is a growing trend towards doing-it-yourself (DIY) portfolio management. Many individual investors have become disillusioned with professional investment management at various levels, to include mutual funds as well as custom-designed professionally-managed portfolios. Consequently, they have become motivated to take their financial futures into their own hands and manage their own portfolios.
Wednesday, April 10, 2013
Why JPMorgan Wants to See Many More Americans on Food Stamps / Companies / Banksters
By: Money_Morning
Every time an American signs up for food stamps in one of 23 states, JPMorgan Chase & Co. (NYSE: JPM) adds to its revenue stream.
That because JPMorgan Chase contracts to operate as the processor of the Electronic Benefits Transfer (EBT) cards in those states. JPMorgan earns a fee for each recipient, ranging from 31 cents to $2.30, depending on the state, every month for the term of the contract.
Read full article... Read full article...
Tuesday, April 09, 2013
Biotechs Stocks with Staggering Profit Potential / Companies / BioTech
By: TLSReport
When it comes to picking biotech stocks, does a buyside perspective matter more than a sellside? Not according to Zacks Investment Research Analyst Grant Zeng, who has straddled the divide. What really matters is research of uncompromised quality. In this interview with The Life Sciences Report, Zeng offers a primer on what he looks for in a biotech investment, and names companies with the potential for big returns.
The Life Sciences Report: Grant, you've been on both the buyside and the sellside. Today you're an analyst at Zacks, a noninvestment bank firm that does not have to solicit business from the companies on which it performs due diligence and research. Is there an advantage for investors in this research model?
Read full article... Read full article...
Sunday, April 07, 2013
The Biggest Investment Trends of Our Lives / Companies / Investing 2013
By: Investment_U
Jason Jenkins writes: Have you heard the news? The ever-evolving world of science, scarce resources and population explosion will alter the world we live in by 2030. In 18 years there will also be a shift in the balance of global power.
This new landscape will be the catalyst for an unprecedented acceleration of political and economic change – so says the U.S. intelligence community. But the question is: Should we change the way we invest in the future?
Read full article... Read full article...
Sunday, April 07, 2013
Why Farmers Are Key to the Commodity Price Cycle / Companies / Agricultural Commodities
By: DailyGainsLetter
Mitchell Clark writes: Farmers really are the best customers.
Monsanto Company (NYSE/MON) has become more than a 10-bagger since listing on the stock market. Its performance over the last year has been good, and the company just beat the Street with its quarterly earnings results.
Friday, April 05, 2013
Stocks Flying High, but What About Risk? / Companies / Company Chart Analysis
By: DailyGainsLetter
Mitchell Clark writes: The performance of many blue chips—consumer staples stocks, in particular—is really stunning. And looking at the shares and how much they’ve moved on the stock market, even since the beginning of the year, you really have to wonder how sustainable this stock market rally is.